BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 28774330)

  • 1. The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review.
    Xiao N; Yu K; Yu S; Wu J; Wang J; Shan S; Zheng S; Wang L; Wang J; Peng S
    World J Surg Oncol; 2017 Aug; 15(1):148. PubMed ID: 28774330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) - new opportunity in two-stage liver resection in patients with colorectal cancer metastases].
    Skipenko OG; Chardarov NK; Bagmet NN; Bedzhanian AL; Polishchuk LO; Shatverian GA
    Khirurgiia (Mosk); 2014; (9):23-9. PubMed ID: 25327741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis.
    Baba K; Oshita A; Kohyama M; Inoue S; Kuroo Y; Yamaguchi T; Nakamura H; Sugiyama Y; Tazaki T; Sasaki M; Imamura Y; Daimaru Y; Ohdan H; Nakamitsu A
    World J Gastroenterol; 2015 Feb; 21(6):1982-8. PubMed ID: 25684967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.
    Jaeck D; Oussoultzoglou E; Rosso E; Greget M; Weber JC; Bachellier P
    Ann Surg; 2004 Dec; 240(6):1037-49; discussion 1049-51. PubMed ID: 15570209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
    Tschuor Ch; Croome KP; Sergeant G; Cano V; Schadde E; Ardiles V; Slankamenac K; Clariá RS; de Santibaňes E; Hernandez-Alejandro R; Clavien PA
    Eur J Surg Oncol; 2013 Nov; 39(11):1230-5. PubMed ID: 23994139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.
    Zhang GQ; Zhang ZW; Lau WY; Chen XP
    Int J Surg; 2014; 12(5):437-41. PubMed ID: 24704086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Left Hepatic Trisectionectomy Including Segment One with New Associated Liver Partition and Portal Vein Ligation with Staged Hepatectomy (ALPPS) Modification: How To Do It?
    Obed A; Jarrad A; Bashir A
    Am J Case Rep; 2016 Oct; 17():759-765. PubMed ID: 27756893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.
    Kremer M; Manzini G; Hristov B; Polychronidis G; Mokry T; Sommer CM; Mehrabi A; Weitz J; Büchler MW; Schemmer P
    J Am Coll Surg; 2015 Sep; 221(3):717-728.e1. PubMed ID: 26232303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.
    Truant S; Scatton O; Dokmak S; Regimbeau JM; Lucidi V; Laurent A; Gauzolino R; Castro Benitez C; Pequignot A; Donckier V; Lim C; Blanleuil ML; Brustia R; Le Treut YP; Soubrane O; Azoulay D; Farges O; Adam R; Pruvot FR;
    Eur J Surg Oncol; 2015 May; 41(5):674-82. PubMed ID: 25630689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma.
    Niekamp AS; Huang SY; Mahvash A; Odisio BC; Ahrar K; Tzeng CD; Vauthey JN
    Eur Radiol; 2020 Jul; 30(7):3862-3868. PubMed ID: 32144462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALPPS procedure with the use of pneumoperitoneum.
    Machado MA; Makdissi FF; Surjan RC
    Ann Surg Oncol; 2013 May; 20(5):1491-3. PubMed ID: 23468045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomy.
    Hasselgren K; Malagò M; Vyas S; Campos RR; Brusadin R; Linecker M; Petrowsky H; Clavien PA; Machado MA; Hernandez-Alejandro R; Wanis K; Valter L; Sandström P; Björnsson B
    Surgery; 2017 May; 161(5):1255-1265. PubMed ID: 28081953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALPPS for primary and secondary liver tumors.
    Vennarecci G; Grazi GL; Sperduti I; Busi Rizzi E; Felli E; Antonini M; D'Offizi G; Ettorre GM
    Int J Surg; 2016 Jun; 30():38-44. PubMed ID: 27112834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
    Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
    Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastasis: the radiologist's perspective.
    Zattar-Ramos LC; Bezerra RO; Siqueira LT; Marques DT; Menezes MR; Herman P; Machado MA; Cerri GG; Leite CC
    Abdom Radiol (NY); 2016 Nov; 41(11):2150-2160. PubMed ID: 27377899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization.
    Matsuo K; Murakami T; Kawaguchi D; Hiroshima Y; Koda K; Yamazaki K; Ishida Y; Tanaka K
    Surgery; 2016 May; 159(5):1289-98. PubMed ID: 26775576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review.
    Hasselgren K; Sandström P; Björnsson B
    World J Gastroenterol; 2015 Apr; 21(15):4491-8. PubMed ID: 25914457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
    Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
    Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases.
    Joechle K; Moser C; Ruemmele P; Schmidt KM; Werner JM; Geissler EK; Schlitt HJ; Lang SA
    World J Surg Oncol; 2017 Mar; 15(1):57. PubMed ID: 28270160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.